TY - JOUR
T1 - Screening of CFTR mutations in an isolated population
T2 - Identification of carriers and patients
AU - Chiba-Falek, Ornit
AU - Nissim-Rafinia, Malka
AU - Argaman, Zvi
AU - Genem, Adnan
AU - Moran, Ilana
AU - Kerem, Eitan
AU - Kerem, Batsheva
N1 - Funding Information:
This work was supported by a grant from the Israel Ministry of Health to B Kerem.
PY - 1998
Y1 - 1998
N2 - One important application of the identification of disease-causing mutations is carrier screening in the general population. Such a project requires a simple accurate test by which a large proportion of the mutations can be identified. This study describes screening for CFTR mutations in an isolated Israeli Arab village. Two mutations, G85E and Δ508, accounted for all the CF alleles of these patients. The screening program tested for these two mutations, as well as the 5T allele, which has recently been shown to down-regulate the CFTR expression and cause variable phenotype. The screened population comprised 497 students from one school, which all the children of the village attend. The results revealed high carrier frequency, 8.5%, for the two CFTR mutations, G85E and ΔF508, and a carrier frequency of 12% for the 5T allele. Two compound heterozygotes for the CFTR mutations, ΔF508/G85E and G85E/5T, were identified. Both of these students had not been diagnosed previously as having CF since their disease presentation was not typical of CF. The CF incidence in this village was found to be extremely high, 1:72 life births. The screening results were reported to the physicians of the village to be used, upon request, for genetic counselling. This study emphasizes the importance of such programs for the identification of non-classical patients and for carrier detection.
AB - One important application of the identification of disease-causing mutations is carrier screening in the general population. Such a project requires a simple accurate test by which a large proportion of the mutations can be identified. This study describes screening for CFTR mutations in an isolated Israeli Arab village. Two mutations, G85E and Δ508, accounted for all the CF alleles of these patients. The screening program tested for these two mutations, as well as the 5T allele, which has recently been shown to down-regulate the CFTR expression and cause variable phenotype. The screened population comprised 497 students from one school, which all the children of the village attend. The results revealed high carrier frequency, 8.5%, for the two CFTR mutations, G85E and ΔF508, and a carrier frequency of 12% for the 5T allele. Two compound heterozygotes for the CFTR mutations, ΔF508/G85E and G85E/5T, were identified. Both of these students had not been diagnosed previously as having CF since their disease presentation was not typical of CF. The CF incidence in this village was found to be extremely high, 1:72 life births. The screening results were reported to the physicians of the village to be used, upon request, for genetic counselling. This study emphasizes the importance of such programs for the identification of non-classical patients and for carrier detection.
KW - CFTR mutations
KW - Carrier frequency
KW - Disease frequency
KW - Genetic diagnosis
KW - Genetic disease screening
KW - Isolated population
UR - http://www.scopus.com/inward/record.url?scp=0031958696&partnerID=8YFLogxK
U2 - 10.1038/sj.ejhg.5200174
DO - 10.1038/sj.ejhg.5200174
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 9781064
AN - SCOPUS:0031958696
SN - 1018-4813
VL - 6
SP - 181
EP - 184
JO - European Journal of Human Genetics
JF - European Journal of Human Genetics
IS - 2
ER -